aubagio
sanofi winthrop industrie - teriflunomide - esclerose múltipla - imunossupressores seletivos - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
aubagio
sanofi-aventis farmacÊutica ltda - teriflunomida - imunomodulador
aubagio
genzyme do brasil ltda - imunomodulador
aubagio
sanofi medley farmacÊutica ltda. - teriflunomida - imunomodulador
cisplatina
accord farmacÊutica ltda - cisplatina - antineoplasico
besilato de cisatracúrio
accord farmacÊutica ltda - besilato de cisatracÚrio - bloqueador neuromuscular
bortyz
accord farmacÊutica ltda - bortezomibe - antineoplasicos citotoxicos
brecila
accord farmacÊutica ltda - cloridrato de epirrubicina - antibioticos antineoplasicos
bortezomibe
accord farmacÊutica ltda - bortezomibe - antineoplasicos citotoxicos
caab
accord farmacÊutica ltda - cabazitaxel - antineoplasico